Expert Interview
A second look: Discussing the full data for Petosemtamab from Merus and the abstract for Ficerafusp alfa for Bicara presented at ASCO
Ticker(s): MRUS, BCAXInstitution: MD Anderson
- Professor of Medicine Thoracic-Head & Neck Med Oncology at The University of Texas MD Anderson Cancer Center.
- Manages 20 patients with HNSCC per week.
- Research focused on defining the biological and molecular effects of the modulation of signal transduction pathways in lung, head and neck, and HPV+ cancers; has defined novel mechanisms of sensitivity and resistance to kinase inhibitors.
How promising is the data for petosemtamab?
Added By: wilson_adminHow promising is the abstract for Ficerafusp alfa
Added By: wilson_adminHow do you envision these investigational agents being used in HSNCC
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
